Table 3.
HSV-1 induced CPE (%) after incubating the MBS extract with the virus and with MRC-5 cell line
| Protocols | Time | aConc.1 | Conc.2 | Conc.3 | Conc.4 | Conc.5 |
|---|---|---|---|---|---|---|
| bDVI | 0 h | 0 % | 0-25 % | 25-50 % | 50-75 % | 100 % |
| 1 h | 0 % | 0 % | 0-25 % | 25-50 % | 50-75 % | |
| 2 h | 0 % | 0 % | 0 % | 0-25 % | 50 % | |
| cIVR | 30 min | 0 % | 0 % | 25-50 % | 50 % | ≥75 % |
| 1 h | 0 % | 0 % | 0-25 % | 25-50 % | 50-75 % |
Note: aConc.: extract concentration (136.58, 68.29, 34.14, 17.07, and 8.53 mg/ml). bDVI: the direct virus inactivation. cIVR: the inhibition in virus infection after specific cell treatment